SCHEMBL3974889

SCHEMBL3974889

NC(=O)c1ccc(-c2ccccc2)c(OCCBr)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 2/20 0.47
MKNK2 Q9HBH9 1/20 0.47
EGFR P00533 1/20 0.46
CYP11B1 P15538 2/20 0.45
CYP11B2 P19099 2/20 0.45
PARP10 Q53GL7 1/20 0.44
CHEK2 O96017 1/20 0.43
PDE4A P27815 1/20 0.42
PDE4B Q07343 1/20 0.42
PDE4C Q08493 1/20 0.42
PDE4D Q08499 1/20 0.42
LMNA P02545 2/20 0.42
RXRA P19793 1/20 0.42
RXRB P28702 1/20 0.42
RXRG P48443 1/20 0.42
L3MBTL1 Q9Y468 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
ROCK2 O75116 1/20 0.41
ROCK1 Q13464 1/20 0.41
MAPK1 P28482 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3972289 0.93 MKNK1 (0.46) MKNK1MKNK2EGFRCYP11B1CYP11B2
SCHEMBL3973587 0.87 MKNK1 (0.48) MKNK1MKNK2EGFRCYP11B1CYP11B2
SCHEMBL3973609 0.86 MKNK1 (0.47) MKNK1MKNK2EGFRCYP11B1CYP11B2
SCHEMBL3976593 0.83 PARP10 (0.42) PARP10PDE4BPDE4DL3MBTL1MAPK1
SCHEMBL9306503 0.83 THRA (0.56) MKNK1MKNK2PDE4APDE4BPDE4C
SCHEMBL5227439 0.82 RXRA (0.59) CYP11B1CYP11B2PARP10RXRARXRB
SCHEMBL2967356 0.78 MKNK1 (0.72) MKNK1MKNK2EGFRPDE4APDE4B
Methane SCHEMBL21358430 0.77 MKNK1 (0.70) MKNK1MKNK2EGFRPDE4APDE4B
SCHEMBL31696706 0.76 EGFR (0.53) EGFRCYP11B1CYP11B2PDE4APDE4B
SCHEMBL30903715 0.73 L3MBTL1 (0.52) MKNK1MKNK2EGFRPARP10CHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2054383-A2 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS SmithKline Beecham Corporation (US) 2009-05-06 EP disclosed
WO-2008021849-A2 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS SMITHKLINE BEECHAM CORPORATION (US) 2008-02-21 WO disclosed